Deutsche Bank analyst Nicole DeBlase placed a “Catalyst Call: Sell ” on shares of Emerson (EMR). The firm sees the company posting an earnings miss in its fiscal Q2. Emerson’s “relatively high” 7% exposure to the Middle East is of greater concern in the near-term, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson initiated with a Market Perform at BMO Capital
- AI Daily: OpenAI said to work on alternative to GitHub
- AI in high-margin hardware should be concern to investors, says Barclays
- OpenAI’s ex-research chief targets AI-driven manufacturing automation, WSJ says
- Emerson Establishes New 364-Day $2 Billion Credit Facility